Using prostate cancer and fibroblast cells, they measured the initial DNA damage, primarily DNA DSBs, and examined the repair kinetics by detecting γH2A.X or 53BP1 using immunofluorescence. The gene discussed is TP53BP1; the disease is prostate cancer.